Clinical Trial Update: Hypertrophic Cardiomyopathy Symptom Release by BX1514M [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BX1514M in hypertrophic cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• BX1514M

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED